Meta-analysis of APOE genotype and subarachnoid hemorrhage: Clinical outcome and delayed ischemia

Neurology

Volumn 69, Issue 8, 2007, Pages 766-775

  Lanterna, L A ^a,g   Ruigrok, Y ^b   Alexander, S ^c   Tang, J ^d   Biroli, F ^a   Dunn, L T ^f   Poon, W S ^e  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^g NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ARTICLE; BRAIN ISCHEMIA; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; COURSE EVALUATION; EMBASE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT INFORMATION; PREDICTION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW;

APOLIPOPROTEIN E4; BRAIN; BRAIN CHEMISTRY; BRAIN ISCHEMIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 34548137334     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000267640.03300.6b     Document Type: Article

References (52)

1. Hop JW, Rinkel GJE, Algra A, van Gijn J. Case-fatality and functional outcome after subarachnoid hemorrhage. A systematic review. Stroke 1997;28:660-664.
2. Dorsch NW. Cerebral arterial spasm - a clinical review. Br J Neurosurg 1995;9:403-412.
3. Mahley RW. Apolipoprotein E cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
4. Laskowitz DT, Horsburgh K, Roses AD. Apolipoprotein E and CNS response to injury. J Cereb Blood Flow Metab 1998;18:465-471.
5. Lanterna LA, Rigoldi M, Tredici G, et al. APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage. Neurology 2005;64:1238-1244.
6. Tang J, Zhao J, Zhao Y, Wang S, Chen B, Zeng W. Apolipoprotein E epsilon 4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surg Neurol 2003;60:391-396.
7. Leung CH, Poon WS, Yu LM, Wong GK, Ng HK. Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 2002;33:548-552.
8. Niskakangas T, Öhman J, Niemelä M, Ilveskoski E, Kunnas TA, Karhunen PJ. Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage. A preliminary study. Stroke 2001;32:1181-1184.
9. Dunn LT, Stewart E, Murray GD, Nicoll JA, Teasdale GM. The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study. Neurosurgery 2001;48:1006-1010.
10. Morris PG, Lindsay WJT, Dunn LT, Nicoll JAR. Apolipoprotein E polymorphism and neuropsychological outcome following subarachnoid hemorrhage. Acta Neurol Scand 2004;109:205-209.
11. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage. Correlation with injury severity and clinical outcome. Stroke 2003;34:637-642.
12. Alexander S, Kerr M, Conley YP, Kong Y, Yonas H. Apolipoprotein E genotype in the subarachnoid hemorrhage population. Nursing Health Sci 2005;7:143-144.
13. Ruigrok YM, Slooter AJ, Bardoel A, Frijns CJ, Rinkel GJ, Wijmenga C. Genes and outcome after aneurysmal subarachnoid hemorrhage. J Neurol 2005;252:417-422.
14. Gao J, Wang H, Sheng H, et al. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 2006;4:25-31.
15. Dodart JC, Marr RA, Koistinaho M, et al. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2005;102:1211-1216.
16. Lynch JR, Wang H, Mace B, et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol 2005;192:109-116.
17. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000;283:2008-2012.
18. Jennett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1975;1:490-484.
19. Rankin J. Cerebral vascular accidents in people over the age of 60, II: prognosis. Scott Med J 1957;2:200-215.
20. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-1060.
21. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14-20.
22. Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988;68:985-986.
23. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 1975;12:189-198.
25. Kim DH, Haney CL, Van Ginhoven G. Utility of outcome measures after treatment for intracranial aneurysms. A prospective trial involving 520 patients. Stroke 2005;36:792-796.
26. World Health Organization. International classification of impairments, disabilities and handicaps. Geneva, Switzerland: World Health Organization, 1980.
27. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-129.
28. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
29. Griffiths J, Barber VS, Morgan L, Young JD. Systematic review and meta-analysis of studies of the timing of tracheostomy in adult patients undergoing artificial ventilation. Br Med J 2005;330:1243-1246.
30. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7:889-894.
31. Macdonald RL. Advances in vascular surgery. Stroke 2004;35:375-380.
32. Gilbert DL, Sethuraman G, Kotagal U, Buncher CR. Meta-analysis of EEG test performance shows wide variation among studies. Neurology 2002;60:564-570.
33. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559-1573.
34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629-634.
35. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J. Temporal alterations in cerebrospinal fluid amyloid β-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 2003;34:e240-e243.
36. Kay AD, Day SP, Nicoll JA, Packard CJ, Caslake MJ. Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage. Atherosclerosis 2003;170:141-146.
37. Ruigrok YM, Slooter AJ, Bardoel A, Frijns CJ, Wijmenga C, Rinkel GJ. Genetic polymorphism and outcome after aneurysmal subarachnoid hemorrhage. Presented at the European Stroke Conference, Valencia, Spain, May 21-24, 2003.
38. Alexander S. Cerebrospinal fluid calcium, APOE protein and genotype in individuals with and without cerebral vasospasm after subarachnoid hemorrhage. Dissertation, Doctor of Philosophy, School of Nursing, University of Pittsburgh, PA.
39. Laskowitz DT, Thekdi AD, Thekdi SD, et al. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp Neurol 2001;167:74-85.
40. Teasdale GM, Murray GD, Nicoll JAR. The association between APOE4, age and outcome after head injury: a prospective cohort study. Brain 2005;128:2556-2561.
41. Kamboh MI. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Gen 2004;68:381-404.
42. Schulz KF, Grimes DA. Multiplicity in randomized trials I: endpoints and treatments. Lancet 2005;365:1591-1595.
43. Janjua N, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 2003;9:113-119.
44. Ohkuma H, Manabe H, Tanaka M, Suzuki S. Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1621-1627.
45. Katusic ZS, Schugel J, Cosentino F, Vanhoutte PM. Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery Am J Physiol 1993;264:H859-H864.
46. Paris D, Town T, Parker TA, Humphrey J, Mullan M. Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide. Neurosci Lett 1998;256:73-76.
47. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 1998;43:863-876.
48. Horsburgh K, McCulloch J, Nilsen M, Roses AD, Nicoll JAR. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischemia. Eur J Neurosci 2000;12:4309-4317.
49. Sheng H, Laskowitz DT, Bennett E, et al. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 1998;18:361-366.
50. Rabinstein AA, Weigand S, Atkinson JLD, Wijdicks EFM. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005;36:992-997.
51. Hopewell S, Clarke M, Lusher A, Lefebvre C, Westby M. A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials. Stat Med 2002;21:1625-1634.
52. Sudlow C, Gonzales NAM, Kim J, Clark C. Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17965 controls. Stroke 2006;37:364-370.